Evidence map›Paper›PMID 38920394›Full record

ArticlemBio2024

A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in

Joël Gyger, Gabriel Torrens, Felipe Cava, Thomas G Bernhardt, Coralie Fumeaux

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Evolution of Resistant Mutants inMicroorganisms · 2025
    Article
  5. Bacterial peptidoglycan as a living polymer.Current opinion in chemical biology · 2025
    Review
  6. Description ofFrontiers in microbiology · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joël GygerInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Gabriel TorrensLaboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Center for Microbial Research (UCMR), Umea, Sweden.
Felipe CavaLaboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Center for Microbial Research (UCMR), Umea, Sweden.ORCID 0000-0001-5995-718X
Thomas G BernhardtHoward Hughes Medical Institute, Chevy Chase, Maryland, USA.ORCID 0000-0003-3566-7756
Coralie FumeauxInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-6969-3111

Funding

Targeting bacterial cell wall biogenesis for the development of novel antimicrobU19AI109764 · NIAID · HARVARD MEDICAL SCHOOL · PI BELTZ, GERALD A · 2014 to 2018
$25.2M
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteriaU19AI158028 · NIAID · HARVARD MEDICAL SCHOOL · PI WALKER, SUZANNE · 2022 to 2025
$10.1M
Peptidoglycan Biogenesis in Escherichia ColiR01AI083365 · NIAID · HARVARD MEDICAL SCHOOL · PI Thomas G Bernhardt · 2010 to 2026
$8.3M
Howard Hughes Medical Institute (HHMI)NIAID NIH HHS R01 AI083365NIAID NIH HHS U19 AI109764NIAID NIH HHS U19 AI158028
6 · The paper itself

Abstract

IMPORTANCE: Inducible beta-lactamases like the ampC system of

Indexed as

Bacterial Proteinsbeta-LactamasesCell WallPseudomonas aeruginosaAnti-Bacterial Agentsbeta-Lactam Resistancebeta-LactamsGene Expression Regulation, BacterialPeptidoglycanPhenotypeAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-LactamsPeptidoglycanbeta-lactamaseslytic transglycosylasepenicillin resistancepeptidoglycan

Identifiers

PMID38920394
PMCPMC11253642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.